KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Non-cash Items (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Non-cash Items for 11 consecutive years, with $7.3 million as the latest value for Q1 2023.

Quarterly Non-cash Items rose 1375.95% to $7.3 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Mar 2023, up 1375.95% year-over-year, with the annual reading at $7.3 million for FY2022, 66.67% down from the prior year.
Non-cash Items for Q1 2023 was $7.3 million at Biolife Solutions, roughly flat from $7.3 million in the prior quarter.
The five-year high for Non-cash Items was $24.5 million in Q1 2021, with the low at $398511.0 in Q2 2020.
Average Non-cash Items over 5 years is $5.6 million, with a median of $1.2 million recorded in 2019.
The sharpest move saw Non-cash Items surged 4190.97% in 2021, then plummeted 97.98% in 2022.
Over 5 years, Non-cash Items stood at $737497.0 in 2019, then fell by 6.98% to $686001.0 in 2020, then decreased by 8.96% to $624531.0 in 2021, then surged by 1068.88% to $7.3 million in 2022, then changed by 0.0% to $7.3 million in 2023.
According to Business Quant data, Non-cash Items over the past three periods came in at $7.3 million, $7.3 million, and $9.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.